Ab initio molecular orbital and force field calculations on the interaction of daunomycin with GC base-pair and intercalation within DNA

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry

Volumn 47, Issue 10, 2008, Pages 1605-1610

  Sarma, Rajib L ^a   Kalita, Rituraj ^a   Karim, Murshida ^a   Bezbaruah, Bipul ^a   Medhi, C ^a  

^a GAUHATI UNIVERSITY   (India)

Author keywords

Ab initio; Daunomycin; DNA; Force field; Interacalation

Indexed keywords

EID: 57749203772     PISSN: 03764699     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gresh N, Pullmann B, Acramone F. Menozzi M & Tonani R, Molecular Pharmacology, 35, 1988, 251.
2. Chaires J B, Biochemistry, 22, 1983, 4202.
3. Chaires J B. Fox J. Herrarra M & Waring M, Biochemistiy, 26, 1998, 8227.
4. Arcamone F, Med Res Rev, 4, 1984, 153.
5. Roche C J, Berkowitz D, Sulikowaski G A, Danishefsky S J & Crothers D M, Biochemistry, 33, 1994, 936.
6. Chaires J B, in Daunomycin binding to DNA: From macroscopic to the microscopic, in molecular basis of specificity in Nucleic Acid-Drug interaction, edited by Pullman B and Jortner J (Kluwer Academic Publishers. Dordrecht, The Netherlands) 1990, 123.
7. Cielplak P, Rao S N, Grootenhius P D J & Kollman P A, Biopolymers, 29, 1990, 717.
8. Jayasena V K & Behe M J, Biopolymers, 31, 1991, 511.
9. Aiyar J, Danishefsky S J & Crothers D M, J Am Chem Soc. 114, 1992, 7552.
10. Leonard G A, Brown T & Hunter W, Eur J Biochem, 204, 1992, 169.
11. Lown J W, in Anthracyclines and Anthracenedione based Anticancer agents, (Elsevier, New York), 1998.
12. Chaires J B, Priebe W, Graves D E & Burke T G, J Am Chem Soc. 115, 1993, 5360.
13. Barr K E, Russell R A, Warrener R N & Grant C J. FEBS Lett. 322, 1993, 173.
14. Baguley B C, Denny W A, Atwell G J & Cain B F, J Med Chem, 24, 1981, 170.
15. Denny W A. Atwell G J & Baguley B C. J Chem Soc. 26, 1983, 1619.
16. Spicer J A. Gamage S A, Atwell A J, Finlay G J, Baguley B C & Denny W A, J Med Chem, 40, 1997, 1919.
17. Finlay G J, Riou J F & Baguley B C, Eur J Cancer, 32A, 1996, 708.
18. Hobza P & Sponer J. Chem Rev, 99, 1999, 3247.
19. Sponer J, Leszczynski J, Vetterl V & Hobza P, J Biomol Struct Dyn. 13, 1996, 695.
20. Sponer J, Leszczynski J & Hobza P, J Phys Chem, 100, 1996, 5590.
21. Sponer J & Kypr J, J Mol Biol, 221, 1991, 776.
22. (a) Medhi C. J Chem Inform and Computer Sciences, 42, 2002, 598;
23. (b) Medhi C, Mitchell J B O & Price S L, Biopolymers (Nucleic Acid Research), 52, 1999, 84;
24. (c) Parajuli R & Medhi C, J Chem Sciences, 116, 2004, 235;
25. (d) Parajuli R, Kalita R & Medhi C, Indian J Chem, 45B, 2006, 782.
26. (a) Frisch M J, Trucks G W, Schlegel H B, Gill P M W, Johnson B G, Robb M A, Cheescman J R, Keith T, Petersson G A, Montgomery J A, Raghavachari K, Al-Laham M A, ZakrzevvakiV G, Ortiz J V, Foresmann J B, Ciolowski J, Stefanov B B, Namayakkara A, Challacombe M, Peng C Y, Ayala P Y, Chen W, Wong M W, Andres J L, Replogle E S, Gomperts R, Martin R L, Fox D J, Binkley J S, Defrees D J, Baker J, Stewart J P, Head-Gordon M, Gonzalez C & Pople J A, Gaussian 94; Gaussian Inc.;
27. (b) CHARMm, Accelrys Inc. San Diego, U.S.A.